Pre-made Brodalumab benchmark antibody ( Whole mAb, anti-IL17RA/IL17R therapeutic antibody, Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-082
Pre-Made Brodalumab biosimilar, Whole mAb, Anti-IL17RA/IL17R Antibody: Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Brodalumab (trade name Siliq in the US and Kyntheum in Europe) is a human monoclonal antibody designed for the treatment of inflammatory diseases.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Pre-Made Brodalumab biosimilar, Whole mAb, Anti-IL17RA/IL17R Antibody: Anti-CANDF5/CD217/CDw217RAR/IMD51/hIL-17R therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Amgen;AstraZeneca;Bausch Health Companies;Kyowa Hakko Kirin;LEO Pharma|
|Conditions Approved||Erythrodermic psoriasis;Plaque psoriasis;Psoriatic arthritis;Pustular psoriasis;Psoriasis|
|Conditions Active||Axial Spondylarthritis;Systemic scleroderma;Palmoplantar pustulosis|
|Conditions Discontinued||Asthma;Crohn's disease;Rheumatoid arthritis|
|Development Tech||Abgenix XenoMouse|